Capital Fund Management (CFM)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62.5M Sell
255,600
-83,900
-25% -$19.5M 0.28% 47
2025
Q4
$70.3M Buy
339,500
+76,100
+29% +$15M 0.2% 97
2025
Q3
$48.8M Sell
263,400
-39,700
-13% -$6.8M 0.13% 199
2025
Q2
$46.3M Buy
303,100
+93,500
+45% +$14.4M 0.13% 224
2025
Q1
$34.8M Buy
209,600
+155,100
+285% +$24.3M 0.1% 279
2024
Q4
$7.88M Sell
54,500
-54,400
-50% -$8.43M 0.02% 862
2024
Q3
$17.6M Buy
108,900
+95,700
+725% +$15.2M 0.05% 501
2024
Q2
$1.93M Sell
13,200
-15,600
-54% -$2.32M 0.01% 1403
2024
Q1
$4.56M Sell
28,800
-130,800
-82% -$20.8M 0.01% 1090
2023
Q4
$25M Buy
159,600
+49,400
+45% +$7.57M 0.07% 378
2023
Q3
$17.2M Sell
110,200
-16,800
-13% -$2.77M 0.06% 411
2023
Q2
$21M Sell
127,000
-188,800
-60% -$30.5M 0.09% 320
2023
Q1
$48.9M Buy
315,800
+253,600
+408% +$40.9M 0.23% 107
2022
Q4
$11M Sell
62,200
-251,800
-80% -$43.5M 0.07% 362
2022
Q3
$51.3M Buy
314,000
+43,500
+16% +$7.36M 0.4% 48
2022
Q2
$48M Buy
270,500
+54,200
+25% +$9.66M 0.44% 36
2022
Q1
$38.3M Buy
216,300
+103,200
+91% +$17.6M 0.31% 59
2021
Q4
$19.3M Sell
113,100
-44,400
-28% -$7.27M 0.14% 204
2021
Q3
$25.4M Buy
157,500
+54,100
+52% +$9.23M 0.19% 136
2021
Q2
$17M Buy
+103,400
New +$17.1M 0.13% 192
2020
Q3
Sell
-72,100
Closed -$10.1M 1300
2020
Q2
$10.1M Sell
72,100
-27,200
-27% -$3.96M 0.16% 183
2020
Q1
$13M Buy
99,300
+63,900
+181% +$9.07M 0.2% 149
2019
Q4
$5.16M Sell
35,400
-19,100
-35% -$2.59M 0.04% 522
2019
Q3
$7.05M Buy
54,500
+7,600
+16% +$1M 0.06% 377
2019
Q2
$6.53M Sell
46,900
-33,700
-42% -$4.66M 0.06% 420
2019
Q1
$11.3M Sell
80,600
-339,500
-81% -$45.5M 0.1% 269
2018
Q4
$54.2M Buy
420,100
+52,900
+14% +$7.38M 0.48% 27
2018
Q3
$50.7M Sell
367,200
-174,400
-32% -$23.2M 0.28% 64
2018
Q2
$65.7M Buy
541,600
+109,800
+25% +$13.7M 0.34% 48
2018
Q1
$55.3M Sell
431,800
-322,100
-43% -$43.5M 0.33% 58
2017
Q4
$105M Buy
753,900
+365,900
+94% +$51M 0.58% 20
2017
Q3
$50.4M Buy
388,000
+206,900
+114% +$27.4M 0.36% 54
2017
Q2
$24M Sell
181,100
-333,300
-65% -$42.5M 0.19% 147
2017
Q1
$64.1M Buy
514,400
+223,100
+77% +$26.7M 0.53% 28
2016
Q4
$33.6M Sell
291,300
-119,400
-29% -$13.8M 0.29% 93
2016
Q3
$48.5M Buy
410,700
+302,900
+281% +$36.7M 0.45% 50
2016
Q2
$13.1M Buy
107,800
+69,700
+183% +$7.92M 0.12% 206
2016
Q1
$4.12M Sell
38,100
-25,100
-40% -$2.6M 0.04% 496
2015
Q4
$6.49M Buy
63,200
+19,100
+43% +$1.92M 0.07% 377
2015
Q3
$4.12M Buy
44,100
+29,900
+211% +$2.89M 0.05% 441
2015
Q2
$1.38M Sell
14,200
-70,800
-83% -$7.09M 0.02% 740
2015
Q1
$8.55M Sell
85,000
-287,700
-77% -$29.3M 0.12% 223
2014
Q4
$39M Buy
372,700
+7,300
+2% +$769K 0.46% 34
2014
Q3
$38.9M Buy
365,400
+43,100
+13% +$4.47M 0.44% 38
2014
Q2
$33.7M Buy
322,300
+154,100
+92% +$15.6M 0.36% 51
2014
Q1
$16.5M Sell
168,200
-81,500
-33% -$7.56M 0.2% 106
2013
Q4
$22.9M Buy
249,700
+68,800
+38% +$6.34M 0.28% 48
2013
Q3
$15.7M Buy
180,900
+139,400
+336% +$12.5M 0.22% 103
2013
Q2
$3.56M Buy
+41,500
New +$3.52M 0.05% 447

Other funds holding JNJ

Capital Fund Management (CFM)'s JNJ Position: Q1 2026 in Review

Capital Fund Management (CFM) sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 37,500 shares — an estimated $8.73M sold.

Capital Fund Management (CFM) first reported a position in JNJ in Q3 2013 and held it in 33 quarters. The position peaked at $136M in Q2 2024. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Capital Fund Management (CFM) reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 37,500 Johnson & Johnson shares in Q1 2026, an estimated $8.73M.
  • Capital Fund Management (CFM) first reported a position in Johnson & Johnson in Q3 2013 and held it in 33 quarters.
  • Capital Fund Management (CFM)'s Johnson & Johnson position peaked at $136M in Q2 2024.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.